Ophthalmic composition for the treatment of ocular infection

An ophthalmic composition for administration to an eye of a patient for the treatment of an ocular infection. The ophthalmic composition contains an ε-polylysine (εPL) in an amount effective to treat or control or prevent the ocular infection.

Saved in:
Bibliographic Details
Main Author Si, Erwin C
Format Patent
LanguageEnglish
Published 12.01.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:An ophthalmic composition for administration to an eye of a patient for the treatment of an ocular infection. The ophthalmic composition contains an ε-polylysine (εPL) in an amount effective to treat or control or prevent the ocular infection.
Bibliography:Application Number: AU20150275896